SWM
JAZZ icon

SHP Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

SHP Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$964 Hold
4
– – ﹤0.01% 1602
2026
Q1 		$756 Hold
4
– – ﹤0.01% 1532
2025
Q4 		$680 Buy
+4
New +$613 ﹤0.01% 1324

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

SHP Wealth Management's JAZZ Position: Q2 2026 in Review

SHP Wealth Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 4 shares worth $964. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

SHP Wealth Management first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • SHP Wealth Management held 4 shares of Jazz Pharmaceuticals worth $964 as of Q2 2026.
  • SHP Wealth Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1602 holding.
  • SHP Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.